Bondada Engineering Limited (BOM:543971)
India · Delayed Price · Currency is INR 437.25
-8.25 (-1.85%)
At close: Aug 1, 2025
Theseus Pharmaceuticals Revenue
In the fiscal year ending March 31, 2025, Bondada Engineering had annual revenue of 15.71B INR with 96.24% growth. Bondada Engineering had revenue of 10.91B in the half year ending March 31, 2025, with 832.56% growth.
Revenue
15.71B
Revenue Growth
+96.24%
P/S Ratio
3.01
Revenue / Employee
27.86M
Employees
564
Market Cap
47.23B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 15.71B | 7.71B | 96.24% |
| Mar 31, 2024 | 8.01B | 4.30B | 116.07% |
| Mar 31, 2023 | 3.71B | 364.78M | 10.92% |
| Mar 31, 2022 | 3.34B | 470.18M | 16.38% |
| Mar 31, 2021 | 2.87B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,765.41B |
| HDFC Bank | 2,736.06B |
| Bharti Airtel | 1,729.85B |
| Tata Consultancy Services | 2,561.48B |
| ICICI Bank | 2,054.85B |
| State Bank of India | 3,429.39B |
| Infosys | 1,672.76B |
| Hindustan Unilever | 638.72B |